Dow Jones

40,211.72

0.53%

Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.

Get Started

(MM) (IDIX)

(MM)

Date:

Regulatory News

Text Search:

Sort by:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:IDIX

<< Previous 1 2 3 4 5 6 7 8 9 10 11 12 13 14 Next >>

Date	Time	Source	Headline	Symbol	Company
12/02/2014	21:17	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:IDIX	(MM)
12/02/2014	21:13	Edgar (US Regulatory)	Initial Statement of Beneficial Ownership (3)	NASDAQ:IDIX	(MM)
11/02/2014	20:13	Edgar (US Regulatory)	Amended Statement of Ownership (sc 13g/a)	NASDAQ:IDIX	(MM)
07/02/2014	17:59	Edgar (US Regulatory)	Amended Statement of Ownership (sc 13g/a)	NASDAQ:IDIX	(MM)
07/02/2014	13:30	GlobeNewswire Inc.	Idenix Pharmaceuticals to Present at the 2014 Leerink Global Healthcare Conference	NASDAQ:IDIX	(MM)
04/02/2014	21:28	Edgar (US Regulatory)	Amended Statement of Beneficial Ownership (sc 13d/a)	NASDAQ:IDIX	(MM)
04/02/2014	21:27	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:IDIX	(MM)
30/01/2014	11:03	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:IDIX	(MM)
29/01/2014	22:01	GlobeNewswire Inc.	Idenix Pharmaceuticals Announces Decision by the United States Patent and Trademark Office Patent Trial and Appeal Board in t...	NASDAQ:IDIX	(MM)
28/01/2014	13:00	GlobeNewswire Inc.	Idenix to Raise $106.7 Million Through Registered Direct Offering	NASDAQ:IDIX	(MM)
13/01/2014	12:00	GlobeNewswire Inc.	Idenix Pharmaceuticals Reports Sustained Virologic Response Rate (SVR4) for Phase II All-Oral Combination Study of Samatasvir...	NASDAQ:IDIX	(MM)
07/01/2014	13:00	GlobeNewswire Inc.	Idenix Pharmaceuticals to Present at the 32nd Annual J.P. Morgan Healthcare Conference	NASDAQ:IDIX	(MM)
06/01/2014	13:00	GlobeNewswire Inc.	Idenix Pharmaceuticals Appoints Jacques Dumas, Ph.D., as Chief Scientific Officer	NASDAQ:IDIX	(MM)
09/12/2013	13:00	GlobeNewswire Inc.	Idenix Pharmaceuticals Announces Declaration of Senior Party in a Second Patent Interference by the USPTO	NASDAQ:IDIX	(MM)
02/12/2013	12:00	GlobeNewswire Inc.	Idenix Pharmaceuticals Announces Initiation of Enrollment in a Phase II All-Oral Combination Study of Samatasvir (IDX719), Si...	NASDAQ:IDIX	(MM)
02/12/2013	12:00	GlobeNewswire Inc.	Idenix Pharmaceuticals Files Patent Infringement and Interference Lawsuits Against Gilead Sciences	NASDAQ:IDIX	(MM)
25/11/2013	21:05	GlobeNewswire Inc.	Idenix Pharmaceuticals to Present at Two Upcoming Healthcare Conferences	NASDAQ:IDIX	(MM)
15/11/2013	13:21	Dow Jones News	Janus Capital Management 3Q 13F: Largest Purchases -2-	NASDAQ:IDIX	(MM)
15/11/2013	13:21	Dow Jones News	Janus Capital Management 3Q 13F: Largest Sales	NASDAQ:IDIX	(MM)
15/11/2013	13:12	Dow Jones News	Fidelity Management & Research Co. 3Q 13F: Largest Eliminations	NASDAQ:IDIX	(MM)
15/11/2013	13:12	Dow Jones News	Fidelity Management & Research Co. 3Q 13F: Largest Sales	NASDAQ:IDIX	(MM)
15/11/2013	13:12	Dow Jones News	Fidelity Management & Research Co. 3Q 13F: Largest Purchases	NASDAQ:IDIX	(MM)
15/11/2013	13:12	Dow Jones News	Fidelity Management & Research Co. 3Q 13F: -2-	NASDAQ:IDIX	(MM)
15/11/2013	13:12	Dow Jones News	Fidelity Management & Research Co. 3Q 13F: -2-	NASDAQ:IDIX	(MM)
15/11/2013	13:12	Dow Jones News	Fidelity Management & Research Co. 3Q 13F: -2-	NASDAQ:IDIX	(MM)
15/11/2013	11:54	Dow Jones News	QVT Financial LP 3Q 13F: Holdings As Of Sep 30	NASDAQ:IDIX	(MM)
01/11/2013	21:52	Edgar (US Regulatory)	Initial Statement of Beneficial Ownership (3)	NASDAQ:IDIX	(MM)
01/11/2013	21:26	Edgar (US Regulatory)	Statement of Beneficial Ownership (sc 13d)	NASDAQ:IDIX	(MM)
30/10/2013	21:00	Edgar (US Regulatory)	Quarterly Report (10-q)	NASDAQ:IDIX	(MM)
30/10/2013	20:16	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:IDIX	(MM)